CurrentCardio
Get Weekly

Cardiovascular journalCurrentCardio coverage

EP Europace

What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.

Recent
41 Briefs
past 90 days
Archive
487 Briefs
research published Jul 2023 – Dec 2026
Editorial
–
no Weekly issue published yet
Impact Factor
10.2
2025 · Journal Citation Reports

Topics

Evidence types

Shares are of the 487 Briefs CurrentCardio has covered from Europace, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from EP Europace

All coverage, newest first

  1. Europace

    Improved patient value after implementing same day discharge for patients undergoing pulmonary vein isolation

    Cohort studyArrhythmias & EP

  2. Europace

    Potassium-Increasing Regimens in Patients at High Risk of Ventricular Arrhythmias: A Prespecified Observational Analysis of the Randomized POTCAST Trial

    Secondary analysisArrhythmias & EP

  3. Europace

    Percutaneous Left Atrial Appendage Closure: The CHAMPION-like vs CLOSURE-like Patient Phenotype Framework

    Research articleArrhythmias & EP

  4. Europace

    Non-invasive assessment of left atrial activation using lead V8 during Bachmann bundle pacing

    Cohort studyArrhythmias & EP

  5. Europace

    Safety and Efficacy of Left Atrial Ablation After Percutaneous Left Atrial Appendage Occlusion in High-Bleeding-Risk Patients with Atrial Fibrillation: A Multicenter Analysis from the PROCEED-AF Ablation Registry

    Cohort studyArrhythmias & EP

  6. Europace

    Progressive conduction system disease preceding hypertrophy in IVS4+919G>A Fabry variant: a population-based electrocardiographic study

    Cohort studyArrhythmias & EP

  7. Europace

    Early rhythm control in patients with atrial fibrillation and cancer: A subgroup analysis of the EAST-AFNET 4 trial

    Secondary analysisArrhythmias & EP

  8. Europace

    Yield of Atrial Fibrillation Screening according to Methodology and Patient Characteristics: An Individual Participant Data Meta-Analysis of 34,165 Individuals Screened for Atrial Fibrillation within the AFFECT-EU/AF-SCREEN Collaboration

    Meta-analysisArrhythmias & EP

  9. Europace

    Associations between specific non-sustained ventricular tachycardia characteristics and sudden cardiac death in hypertrophic cardiomyopathy

    Cohort studyArrhythmias & EP

  10. Europace

    Late arrhythmias following Fontan completion: insights from a Korean Multicentre Fontan Registry of over 1000 extracardiac conduit surgeries

    Cohort studyCongenital

  11. Europace

    COnCOmitaNt pulsed field ablation-based pUlmonary vein isolation and lefT atrial appendage closure: the COCONUT study

    Cohort studyArrhythmias & EP

  12. Europace

    Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction

    Cohort studyArrhythmias & EP

  13. Europace

    Patient-reported outcome measures for atrial fibrillation: a systematic review and evaluation of psychometric properties of symptom severity measures

    Meta-analysisArrhythmias & EP

  14. Europace

    Incident heart failure in patients with screening-detected atrial fibrillation: a post hoc analysis of the STROKESTOP and STROKESTOP II studies

    Secondary analysisArrhythmias & EP

  15. Europace

    Edoxaban antithrombotic therapy in diabetic patients with atrial fibrillation and stable coronary artery disease: the EPIC-CAD trial

    Randomised controlled trialArrhythmias & EP

  16. Europace

    Pulmonary vein isolation durability in a randomized trial comparing fluoroscopy-only vs. electroanatomic mapping strategies for pulmonary vein isolation with balloon-in-basket pulsed-field ablation

    Randomised controlled trialArrhythmias & EP

  17. Europace

    Identifying patients at low risk for atrial fibrillation after cryptogenic stroke: the PAVA score

    Diagnostic or prognostic studyArrhythmias & EP

  18. Europace

    Cryoballoon ablation vs. antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: the multicentre randomized CEPAF trial

    Randomised controlled trialArrhythmias & EP

  19. Europace

    Digital recruitment and prevalence of screen-detected atrial fibrillation in nationwide patch-based ECG screening: the NORSCREEN randomized clinical trial

    Secondary analysisArrhythmias & EP

  20. Europace

    Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III

    Randomised controlled trialArrhythmias & EP

  21. Europace

    Development and validation of the GLORIA-AF Stroke Weighted Risk Score for patients with atrial fibrillation

    Diagnostic or prognostic studyArrhythmias & EP

  22. Europace

    Safety and Effectiveness of a Novel Dual-Energy Radiofrequency/Pulsed Field Ablation Catheter: 12 Month Results of the FlexPulse Study

    Cohort studyArrhythmias & EP

  23. Europace

    Non-linear associations between blood pressure and clinical outcomes in atrial fibrillation: A systematic review and dose-response meta-analysis

    Meta-analysisArrhythmias & EP

  24. Europace

    Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

    Guideline or statementHeart failure

  25. Europace

    Diagnosis and management of very rare primary arrhythmia syndromes in children and adults: a Clinical Consensus Statement of the European Heart Rhythm Association of the ESC and the Association of Cardiovascular Nursing & Allied Professions of the ESC, endorsed by the Association for European Paediatric and Congenital Cardiology

    Guideline or statementArrhythmias & EP

  26. Europace

    Cognitive function and telemedicine-based, village doctor-led care for atrial fibrillation

    Secondary analysisArrhythmias & EP

  27. Europace

    Long-term incidence of infective endocarditis according to the type of cardiac implantable electronic device: a nationwide comparison with moderate- and high-risk patient groups

    Cohort studyCardio-oncology & other

  28. Europace

    Artificial intelligence-intracardiac echocardiography-guided pulsed field ablation of atrial fibrillation with variable-loop circular catheter

    Cohort studyArrhythmias & EP

  29. Europace

    Outcomes of Amulet occluder implantation following Watchman screen failure in the ADVANCE LAA study: a real-world analysis of procedural success and safety

    Secondary analysisValvular & structural

  30. Europace

    Practical guide on the use of the PulseSelect pulsed field ablation system for atrial fibrillation ablation procedures

    Guideline or statementArrhythmias & EP

  31. Europace

    The evolution of Extravascular Cardioverter Defibrillator implantation: feasibility in a purely electrophysiologic setting

    Cohort studyArrhythmias & EP

  32. Europace

    Ventricular pulsed field ablation from bench to bedside: preclinical and clinical evidence from a systematic review and meta-analysis

    Meta-analysisArrhythmias & EP

  33. Europace

    Management of recurrent atrial fibrillation after catheter ablation: 5-year outcomes of repeat catheter ablation vs. antiarrhythmic therapy

    Cohort studyArrhythmias & EP

  34. Europace

    Conduction system pacing vs. biventricular pacing for cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis considering randomized controlled trials and observational studies

    Meta-analysisHeart failure

  35. Europace

    Conduction system vs. biventricular pacing in heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials

    Meta-analysisHeart failure

  36. Europace

    Redefining response to cardiac resynchronization therapy: a post hoc analysis of the MORE-CRT MPP trial

    Secondary analysisHeart failure

  37. Europace

    Residual thromboembolic risk and outcomes of oral anticoagulation discontinuation after atrial fibrillation ablation: a target trial emulation

    Cohort studyArrhythmias & EP

  38. Europace

    Haemolysis and renal effects across pulsed field ablation systems in atrial fibrillation

    Cohort studyArrhythmias & EP

  39. Europace

    Comparative evaluation of left atrial appendage occlusion and oral anticoagulation: a Bayesian meta-analysis of randomized controlled trials

    Meta-analysisArrhythmias & EP

  40. Europace

    Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials

    Meta-analysisArrhythmias & EP

All 487 Briefs in ExploreShowing the 40 most recently published